Medpace Hldgs (NASDAQ:MEDP) is preparing to release its quarterly earnings on Monday, 2026-02-09. Here’s a brief overview of what investors should keep in mind before the announcement.
Analysts expect Medpace Hldgs to report an earnings per share (EPS) of $4.21.
The announcement from Medpace Hldgs is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It’s worth noting for new investors that guidance can be a key determinant of stock price movements.
Historical Earnings Performance
In the previous earnings release, the company beat EPS by $0.32, leading to a 9.12% increase in the share price the following trading session.
Here’s a look at Medpace Hldgs’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 3.54 | 2.99 | 3.08 | 3.12 |
| EPS Actual | 3.86 | 3.10 | 3.67 | 3.67 |
| Price Change % | 9.00 | 55.00 | -2.00 | -8.00 |
Tracking Medpace Hldgs’s Stock Performance
Shares of Medpace Hldgs were trading at $541.27 as of February 04. Over the last 52-week period, shares are up 52.68%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
Analyst Views on Medpace Hldgs
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Medpace Hldgs.
A total of 2 analyst ratings have been received for Medpace Hldgs, with the consensus rating being Neutral. The average one-year price target stands at $562.5, suggesting a potential 0.17% upside.